Literature DB >> 11271387

Does the tuberous sclerosis complex include clivus chordoma? A case report.

J Börgel, H Olschewski, T Reuter, B Miterski, J T Epplen.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11271387     DOI： 10.1007/s004310000645

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  14 in total

1.  STAT3 Inhibition as a Therapeutic Strategy for Chordoma.

Authors:  Anthony C Wang; John H Owen; Waleed M Abuzeid; Shawn L Hervey-Jumper; Xiaobing He; Mikel Gurrea; Meijuan Lin; David B Altshuler; Richard F Keep; Mark E Prince; Thomas E Carey; Xing Fan; Erin L McKean; Stephen E Sullivan
Journal:  J Neurol Surg B Skull Base       Date:  2016-05-31

Review 2.  Infantile clivus chordoma without clivus involvement: case report and review of the literature.

Authors:  D Kombogiorgas; E J St George; S Chapman; M English; G A Solanki
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

3.  Chordoma Occurs in Young Children With Tuberous Sclerosis.

Authors:  Nathan A Dahl; Timothy Luebbert; Michele Loi; Ilana Neuberger; Michael H Handler; Bette Kay Kleinschmidt-DeMasters; Jean M Mulcahy Levy
Journal:  J Neuropathol Exp Neurol       Date:  2017-06-01       Impact factor: 3.685

4.  Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population.

Authors:  Mary L McMaster; Alisa M Goldstein; Dilys M Parry
Journal:  J Med Genet       Date:  2011-01-25       Impact factor: 6.318

Review 5.  Systemic therapy options for unresectable and metastatic chordomas.

Authors:  Silvia Stacchiotti; Paolo Giovanni Casali
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

Review 6.  The biological basis for modern treatment of chordoma.

Authors:  Roberto Jose Diaz; Michael D Cusimano
Journal:  J Neurooncol       Date:  2011-03-08       Impact factor: 4.130

7.  Generation of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordoma.

Authors:  Jason M Davies; Aaron E Robinson; Cynthia Cowdrey; Praveen V Mummaneni; Gregory S Ducker; Kevan M Shokat; Andrew Bollen; Byron Hann; Joanna J Phillips
Journal:  J Neurosurg       Date:  2013-11-29       Impact factor: 5.115

8.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

9.  Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.

Authors:  Sangyeul Han; Carolyn Polizzano; Gunnlaugur P Nielsen; Francis J Hornicek; Andrew E Rosenberg; Vijaya Ramesh
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

10.  Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.

Authors:  Lucia Ricci-Vitiani; Daniele Runci; Quintino Giorgio D'Alessandris; Tonia Cenci; Maurizio Martini; Federico Bianchi; Giulio Maira; Louis Stancato; Ruggero De Maria; Luigi Maria Larocca; Roberto Pallini
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.